Update from the Diabetic Foot Global Conference (DFCon) 2007.
D000671:Amputation, Surgical / Q000009:adverse effects / Q000379:methods; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003646:Debridement / Q000379:methods; D017719:Diabetic Foot / Q000517:prevention & control* / Q000628:therapy*; D005260:Female; D006801:Humans; D007391:International Cooperation; D008297:Male; D013530:Surgical Wound Infection / Q000382:microbiology / Q000628:therapy*; D016896:Treatment Outcome; D014481:United States; D014656:Vascular Surgical Procedures / Q000009:adverse effects / Q000379:methods; D014945:Wound Healing / Q000502:physiology
D000900:Anti-Bacterial Agents